Eli Lilly & Co. is now selling vials of its blockbuster weight-loss drug Zepbound to patients for as little as $399 a month as it works to overcome supply shortages of wildly popular shots.
Subscribe to continue reading this article.
Already subscribed? To login in, click here.
Originally Published: August 27, 2024 at 10:54 a.m.
